Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
India
/
Pharmaceuticals & Biotech
Create a narrative
Indegene Community
NSEI:INDGN Community
1
Narratives
written by author
0
Comments
on narratives written by author
8
Fair Values set
on narratives written by author
Create a narrative
Indegene
Popular
Undervalued
Overvalued
Community Investing Ideas
Indegene
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
M&A And Cortex Integration Will Expand Enterprise Opportunities
Key Takeaways M&A activities and AI integration signal innovation and efficiency, likely boosting topline growth and improving net margins through cost reductions. Strengthening pharma partnerships and strategic acquisitions are poised to enhance revenue, earnings, and shareholder value by expanding capabilities and cost-effectiveness.
View narrative
₹611.00
FV
2.4% undervalued
intrinsic discount
12.71%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
Updated
narrative
Your Valuation for
INDGN
INDGN
Indegene
Your Fair Value
₹
Current Price
₹596.30
49.7% overvalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
50b
2015
2018
2021
2024
2025
2027
2030
Revenue ₹49.8b
Earnings ₹7.1b
Advanced
Set Fair Value